Table 1.
Characteristics of the included studies
| Reference | Country | Year of publication | Type of study | Duration | Group | Dropout | Mean age (years) | ||
|---|---|---|---|---|---|---|---|---|---|
| Control | Intervention | Control | Intervention | ||||||
| [29] | Russia | 2010 | RCT | 16 weeks | 36 obese premenopausal women patients with NAFLD | 36 obese premenopausal women patients with NAFLD | 0 patient | 0 patient | 37.4 ±2.8 (control group) and 36.1 ±2.1 (intervention group) |
| [25] | Iran | 2012 | RCT | 3 months | 43 patients | 33 patients | 10 patient | 12 patient | 47.10 ±8.27 (control group) and 51.00 ±7.94 (intervention group) |
| [26] | Iran | 2014 | RCT | 8 months | 26 (15 men) | 26 patients (15 men) | 4 patients | 1 patient | 37.73 ±8.24 (control group) and 37.0 ±7.45 (intervention group) |
| [27] | Taiwan | 2019 | RCT | 12 weeks | 21 patients (11 men and 10 women) | 21 patients (7 men and 14 women) | 1 patient | 1 patient | 59 ±10.5 (control group) and 55 ±12.5 (intervention group) |
| [28] | Taiwan | 2021 | RCT | 6 months | 21 patients (11 men and 10 women) | 21 patients (7 men and 14 women) | 0 patient | 0 patient | 59 ±10.5 (control group) and 55 ±12.5 (intervention group) |